Table: Modalis Therapeutics - 9-MTH group results

Modalis Therapeutics

07/11/2025 06:35

Nov 7 (Reuters)- 
             Modalis Therapeutics Corporation 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Sep 30, 2025        Sep 30, 2024     Dec 31, 2025 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Operating       loss 1.82           loss 1.06                   
  Recurring       loss 1.80           loss 1.06                   
  Net             loss 1.80           loss 1.06                   
  EPS          loss 23.91 yen      loss 27.21 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div            NIL                 NIL                      
  -Q4 div                                NIL              NIL     
  
  NOTE - Modalis Therapeutics Corporation. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4883.T